
Patients with polyendocrine metabolic ovarian syndrome have higher ocular disease prevalence.
Orlando-Optic nerve head (ONH) imaging forms an essential part of the management of suspected glaucoma, as well as in patients with established glaucomatous visual field loss, according to a London glaucoma specialist.



